C.M. Bidwell & Associates »

Bridgebio Pharma shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $202k 2.7k 74.26

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Schwab Strategic Tr sht tm us tres (SCHO)
Vanguard Malvern Fds strm infproidx (VTIP)
Vanguard Total Stock Market ETF (VTI)
iShares Russell 2000 Index (IWM)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Vanguard Europe Pacific ETF (VEA)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Total Bond Market ETF (BND)
Schwab Strategic Tr 0 (SCHP)
Dimensional Etf Trust (DFAC)
Vanguard Intermediate-Term Bond ETF (BIV)

View all positions for C.M. Bidwell & Associates

Top funds holding Bridgebio Pharma

BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
Jane Street
State Street Corporation
Geode Capital Management
Invesco
Susquehanna International
Frazier Life Sciences Management

View all funds holding Bridgebio Pharma